Korro Bio (KRRO)

• Market cap: $110M
• 1 day: -3.07%
• 5 days: -19.8%
• 1 month: -5.47%
• 3 months: 40.36%
• 6 months: -69.32%
• Year to date: 37.39%
• 1 year: -53.37%
• 5 years: -99.35%
• 10 years: -98.39%
• Sector: Healthcare
• Industry: Biotechnology

About: Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Employees: 87